About Logan Snyder
Logan Snyder is a director at Alloy Therapeutics.
Logan Snyder first appears on SEC filings in 2021.
Experience
This experience comes from Logan Snyder's profile and from SEC filings. For roles taken from filings, the years are when the filings name Logan Snyder in the role, so the role may have started earlier or lasted longer.
TI
Therio, Inc. Current
Co-Founder, CEO
2024 – Present
IN
Inkshares Current
Board Member
2022 – Present
Alloy Therapeutics, Inc. Current
Advisor (2017 – Present)
Director
2017 – Present · Waltham, MA
Drug discovery platforms and development services for biotech companies, pharmaceutical firms and academic researchers.
UH
Ulysses Diversified Holdings Current
Partner
2017 – Present
NR
New England Free Jacks Rugby
Board Member
2018 – 2026
FF
Fortune Favors Films
Co-Founder, Executive Producer
2019 – 2025
TO
The Onion
VP, Business & Legal Affairs, General Counsel
2014 – 2017
HI
Human Care Systems, Inc.
Director, Finance
2013
GS
GL Investment Services
Vice President
2010 – 2013
UD
University of Notre Dame
MBA, Investments & Entrepreneurship
2009 – 2010
RL
RISC, LLC
Attorney, Errors & Omissions Counsel
2008 – 2009
GE
GE
Supply Chain Management
2004 – 2006
UB
UBS
Intern
2004
Key Colleagues at Startups
The people Logan Snyder works with at each company, as listed on that company's latest Form D.
Alloy Therapeutics, Inc. · Form D, Apr 15, 2026
AS
Anthony Sun
Director
AH
Alaa Halawa
Director
UN
Ulrik Nielsen
Director
JC
Jason Camm
Director
JC
Jason Coloma
Director
CK
Christian Kanady
Director
AK
Alex Kolicich
Director
Errik Anderson
Founder, CEO, Chairman of Alloy
Piotr Bobrowicz
Chief Scientific Advisor and director